Scientists have developed a biological system which lets cells form a desired shape by moulding their surrounding material – initially creating the world’s first self-curving cornea
The cornea is the clear outer layer at the front of the eye ball.
In the research, a flat circle of gel containing corneal stromal cells (stem cells) was activated with a serum so that the edges of the gel contracted at a different rate to the centre, drawing up the edge over the course of 5 days to form a bowl-like curved cornea.
This time-lapsed video shows this astonishing process
The research is published in Advanced Functional Materials and was led by Professor Che Connon, professor of tissue engineering, Newcastle University. He says: “Currently there is a shortage of donated corneas which has worsened in recent years, as they cannot be used from anyone who has had laser eye surgery so we need to explore alternatives such as these self-curving corneas.
“The cells are triggered into forming a complex 3D structure, but as this requires time to occur, the fourth dimension in this equation, we have labelled them 4D structures.”
The 4D formation is achieved by the innovative use of cells as biological actuators, components which get the parts moving. In this case, the cells themselves force the surrounding tissue to move in a pre-determined manner over time.
The technology and understanding we have developed holds enormous potential as these corneas show that engineered tissue shape can be controlled by cell actuators
Remodelling the structure from the inside
The gel, comprising collagen and encapsulated corneal cells, was laid out in two concentric circles. The formation of the curved shape which has a bowl-like structure was obtained by adding molecules called peptide amphiphiles to either one of the circles.
In one ring the active cells were pulling the internal structure of the gel (high contraction), in the other they were pulling these peptide amphiphile molecules (low contraction). This difference in contraction between the two concentric rings caused the curvature of the gel.
This happened because the cells preferred to bind to the peptide amphiphile molecules rather the internal structure of the gels.
Professor Connon added: “Because all the process was orchestrated by the cells themselves, we can envision them as bio-machines remodelling these structures from the inside.
“The technology and understanding we have developed holds enormous potential as these corneas show that engineered tissue shape can be controlled by cell actuators. This may lead us to imagine a future where such an approach can be combined with key-hole surgery enabling a surgeon to implant tissue in one shape which then develops into a more complex, functional shape within the body, driven by the behaviour of the cells themselves.”
Dr Martina Miotto, lead author on the paper explained: “This is a cutting-edge example of the strict relationship between form and function as the research also showed that the biomechanical and bio-functional properties of these 4D structures reproduced those of the native tissue, with undifferentiated corneal limbal epithelial stem cells located in the softer limbus and the differentiated epithelium spanning the stiffer centre of the anterior cornea.”
The team intend to take the work forward over the next few years with a view to refining the technique as a potential method of manufacturing corneas for human transplant.
The Latest on: 4D tissues
via Google News
The Latest on: 4D tissues
- Uhuru creates Kenya Tissue and Transplant Authorityon August 3, 2022 at 7:17 am
President Uhuru Kenyatta has established the Kenya Tissue and Transplant Authority to handle all human tissue transplant procedures in the country. The establishment of the authority replaces the ...
- Precise Bio Partners with Carl Zeiss Meditec to Develop 4D-Printed Corneal Transplantson July 26, 2022 at 7:52 am
Carl Zeiss Meditec has entered into a partnership with regenerative medicine company Precise Bio to develop and commercialize its technology to 4D print transplantable corneal tissue. The products are ...
- Higher Ed Researchers Grow Living Cells with 4D Printingon July 24, 2022 at 5:23 am
The newest frontier of 4D printing is growing tissues and organs in a lab setting. That’s happening at the Wake Forest Institute for Regenerative Medicine, where researchers recently 3D-printed ...
- 4D Printing in Healthcare Market Growth Opportunities, Top Companies And Forecast To 2029on July 20, 2022 at 5:00 pm
The 4D Printing in Healthcare market is projected ... Inc. for the development of organs and engineered tissues. The market is segmented by component into hardware, software, and services.
- Precise Bio partners with ZEISS to develop bio-printed cornea implantson July 20, 2022 at 4:21 am
We’re one step closer to a 1950s sci-fi writer’s vision of the future of medicine. On Monday, Medical technology company Carl Zeiss Meditec (ZEISS) entered into a partnership with Precise Bio ...
- 3D Bioprinting for Tissue and Organ Regeneration Market worth $424.3 Million by 2030 - Exclusive Report by InsightAce Analyticon July 20, 2022 at 4:00 am
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global 3D Bioprinting for Tissue and Organ Regeneration Market By Type (Magnetic 3D Bioprinting, ...
- A single MRI scan can manage respiratory motionon July 19, 2022 at 3:06 pm
For treatments using an MRI-guided linac, free-breathing 4D-MRI is a promising alternative to 4D-CT for motion management, providing excellent soft-tissue contrast with no ionizing radiation.
- Precise Bio Catches Carl Zeiss Meditec's Eyeon July 19, 2022 at 5:42 am
Precise Bio combines engineering, biomaterials, cell technology, bioengineering, and 3D printing into a 4D bio-fabrication platform for transplantable organs and tissues. The company's technology ...
- Carl Zeiss invests in Precise Bio's fabricated corneason July 18, 2022 at 5:15 am
Israeli company Precise Bio has today announced a collaboration on the development and commercialization of fabricated corneal tissue with Germany's Carl Zeiss Meditec. Carl Zeiss Meditec will invest ...
- Carl Zeiss Meditec and Precise Bio Announce Partnership in the Development and Commercialization of Tissue-Based Implants for Ophthalmologyon July 18, 2022 at 3:17 am
The companies will jointly develop 4D bio-fabricated corneal transplants for diseases that require endothelial keratoplasty and natural lenticule transplants Carl Zeiss Meditec will invest in ...
via Bing News